Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments (2016 - 2017)

Viridian Therapeutics, Inc.\DE has reported Preferred Dividend Payments over the past 2 years, most recently at $5000.0 for Q1 2017.

  • Quarterly results put Preferred Dividend Payments at $5000.0 for Q1 2017, up 141.67% from a year ago — trailing twelve months through Dec 2017 was $5000.0 (down 80.0% YoY), and the annual figure for FY2017 was $5000.0, down 89.8%.
  • Preferred Dividend Payments for Q1 2017 was $5000.0 at Viridian Therapeutics, Inc.\DE, down from $12000.0 in the prior quarter.
  • Over the last five years, Preferred Dividend Payments for VRDN hit a ceiling of $13000.0 in Q3 2016 and a floor of -$12000.0 in Q1 2016.